Science Corporation
Develops brain-computer interface retinal implants to restore vision in patients with retinal diseases
$230MSeries C
Role not disclosedI
IQT
Activity from announced rounds
Activity in this selectionUnited States · Mar 31, 2026 · Mar 1, 2026
- Rounds participated in
- 2
- Confirmed lead rounds
- — 2 roles undisclosed
- New companies
- 2 First participation on record · 0 follow-on
- Funding in participating rounds
- $730M 2 disclosed · full round size, not this investor’s share